Anzeige
Mehr »
Login
Montag, 20.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
GOLD-MINEN vor Jahrhundert-Hausse?! Diese Aktie sofort kaufen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2P85Z | ISIN: US67080M1036 | Ticker-Symbol:
NASDAQ
17.05.24
21:59 Uhr
16,580 US-Dollar
+1,180
+7,66 %
1-Jahres-Chart
NURIX THERAPEUTICS INC Chart 1 Jahr
5-Tage-Chart
NURIX THERAPEUTICS INC 5-Tage-Chart

Aktuelle News zur NURIX THERAPEUTICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiNurix Therapeutics, Inc.: Nurix Therapeutics Announces Upcoming Oral Presentation of New Data from Ongoing Clinical Trial of NX-5948, a Selective Bruton's Tyrosine Kinase (BTK) Degrader, at the European Hematology Association Congress (EHA2024)4
DiKey Takeaways From Nurix Therapeutics Analyst Ratings2
07.05.Nurix Therapeutics, Inc.: Nurix Therapeutics to Participate in RBC Capital Markets Global Healthcare Conference2
17.04.Nurix Therapeutics, Inc.: Nurix Therapeutics Announces Closing of Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares3
12.04.Applied Digital Reports Downbeat Results, Joins Nurix Therapeutics And Other Big Stocks Moving Lower In Friday's Pre-Market Session-
12.04.Nurix Therapeutics drops after upsized $175 million stock offering2
12.04.Biggest stock movers today: NRIX and APLD1
12.04.Nurix Therapeutics prices upsized stock offering to raise $175.0 million1
12.04.Nurix Therapeutics, Inc.: Nurix Therapeutics Announces Pricing of Upsized $175.0 Million Public Offering4
12.04.Nurix Therapeutics Announces $125 Mln Public Stock Offering; Stock Down In After-hours-
11.04.Nurix Therapeutics Inc reports results for the quarter ended in February - Earnings Summary1
11.04.Nurix Therapeutics announces proposed public offering3
11.04.Nurix Therapeutics, Inc.: Nurix Therapeutics Announces Proposed Public Offering4
10.04.Nurix (NRIX) Up on Upbeat Initial Data From Phase I Cancer Study2
10.04.Nurix Therapeutics, Inc. Q1 Loss increases, but beats estimates1
10.04.Nurix Therapeutics GAAP EPS of -$0.76 beats by $0.04, revenue of $16.59M misses by $0.5M2
10.04.Nurix Therapeutics, Inc. - 10-Q, Quarterly Report1
10.04.Nurix Therapeutics, Inc.: Nurix Therapeutics Reports First Quarter Fiscal 2024 Financial Results and Provides a Corporate Update149Extended the Strategic Collaboration with Gilead Sciences Extended the Strategic Collaboration with Sanofi to Develop Novel Orally Available Targeted Protein Degrader of STAT6 Presented new case studies...
► Artikel lesen
09.04.Nurix gains after extending Sanofi research pact136
09.04.Nurix Therapeutics, Inc. - 8-K, Current Report1
Seite:  Weiter >>
58 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1